Gilead’s HIV Pipeline Targets Needs & Advances Public Health
Gilead Sciences has revealed a range of positive data from its HIV research pipeline, showcasing its innovative treatment strategies....
Unique Thyroid Cancer Tests: New Hope Unveiled
In the rapidly evolving landscape of medical research, particularly in the realm of cancer treatment, the development and application...
AbbVie, OSE Partner for Novel Anti-Inflammatory Antibody
AbbVie Inc. and OSE Immunotherapeutics SA have announced a strategic partnership to develop OSE-230, a monoclonal antibody in the...
Your New Guide to Validate Clinical Trial DHTs
The advent of sensor-based Digital Health Technologies (sDHTs) is transforming the landscape of clinical research and patient care. I...
SCRI & AstraZeneca Forge Alliance for Cancer Research Tech
Sarah Cannon Research Institute (SCRI), a global leader in conducting community-based clinical trials, has announced a collaboration with AstraZeneca...
FDA Priority Review for Epcoritamab in Refractory Lymphoma
Genmab A/S and AbbVie have received Priority Review from the FDA for epcoritamab-bysp, a bispecific antibody for the treatment...
New Tips to Incorporate DCT Elements in Your Clinical Trials
In a pivotal webcast hosted by Medable, a panel of distinguished experts, including Pamela Tenaerts (Chief Scientific Officer at...
Mandara III Data: Fasenra Aids EGPA Remission, NEJM Reports
Positive results from the MANDARA Phase III trial for FASENRA® (benralizumab) in patients with eosinophilic granulomatosis with polyangiitis (EGPA)...
Biktarvy by Gilead: FDA Approval for Resistant HIV Cases
Gilead Sciences, Inc. has announced the FDA’s approval of an expanded indication for Biktarvy® to treat people with HIV...
Merck’s Keytruda Gets Positive CHMP Opinion for NSCLC Therapy
Merck announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...